AI delivers evidence-based mental health interventions at scale through digital therapeutics, therapy augmentation, and measurement-based care — addressing the access crisis in behavioral health.
AI mental health & digital therapeutics is represented by 6 published case-study records and 0 linked vendors in this banking directory. 6 records retain cited source URLs. The largest concentration is Mental & Behavioral Health, with Large Language Models & Generative AI the most common technology. Outcomes are attributed to each record's source when available rather than independently verified.
Limitation: Missing linked evidence is unknown and does not prove absence of capability.
Digital therapeutics (DTx) for mental health represent a new treatment modality — software-based interventions that deliver evidence-based therapy protocols (CBT, DBT, ACT) through apps and AI chatbots, validated through clinical trials with the same rigor expected of pharmaceutical products. The mental health access crisis (150+ million Americans in shortage areas, average 48-day wait for a first therapy appointment) demands scalable solutions, and AI-powered DTx can reach patients who would otherwise go untreated.
Woebot Health is the most clinically validated AI mental health DTx, with a randomized controlled trial published in NEJM AI demonstrating efficacy for their GenAI-powered CBT delivery platform. The system uses conversational AI to guide patients through evidence-based cognitive behavioral therapy techniques — cognitive restructuring, behavioral activation, mood tracking, and psychoeducation — available 24/7 without appointment or waitlist barriers. Spring Health deploys AI to personalize the entire mental health care pathway, using predictive models to match employees with the right intervention level (self-guided AI, coaching, therapy, or psychiatry) from the first interaction, reducing time-to-remission. Eleos Health takes a different approach — augmenting human therapists rather than replacing sessions, with AI that analyzes therapy sessions to provide objective outcome measures and treatment fidelity scoring.
Measurement-based care (MBC) powered by AI addresses a critical gap: fewer than 20% of mental health providers systematically track patient outcomes using validated instruments. AI automates the administration, scoring, and trend analysis of measures like PHQ-9 (depression), GAD-7 (anxiety), and PCL-5 (PTSD), providing clinicians and supervisors with real-time dashboards showing treatment response across their patient panel. AI flags patients who aren't improving as expected, enabling timely treatment adjustments — switching modalities, adjusting medication, or increasing session frequency — before patients disengage. This data-driven approach has been shown to improve therapy outcomes 20-30% compared to treatment-as-usual without systematic outcome measurement.
Yes, with growing evidence. Woebot Health's RCT published in NEJM AI demonstrated clinical efficacy for AI-delivered CBT. Multiple smaller trials show AI chatbots reduce depression and anxiety symptoms significantly more than waitlist controls. The evidence is strongest for mild-to-moderate depression and anxiety using structured CBT protocols. AI chatbots are not recommended as sole treatment for severe mental illness, suicidal ideation, or psychotic disorders — these require human clinical care. The appropriate framing is AI as a scalable first-line intervention for mild-moderate conditions and an adjunct for more severe presentations.
Virtua Health
Dartmouth University Geisel School of Medicine
Dartmouth College
Dartmouth Health
Dartmouth Center for Technology and Behavioral Health (CTBH)
Get your AI solutions in front of decision-makers actively researching this space.
Learn about vendor listings →